Spotting synovial sarcoma: July is Sarcoma Awareness Month
Sarcoma Awareness Illustration
July is Sarcoma Awareness Month, a significant time dedicated to increasing public awareness of sarcoma—a group of rare cancers that develop in bones and soft tissues. Among these, synovial sarcoma stands out as a particularly aggressive and life-threatening form, often affecting young adults.
What is Synovial Sarcoma?
Synovial sarcoma is a rare type of soft tissue cancer that typically develops near joints such as the knee, hip, ankle, or shoulder. One of the hallmark symptoms is a painful lump or swelling, which can easily be mistaken for a benign injury or inflammation in its early stages. However, the condition is far more serious and requires prompt medical attention.
“Early disease testing, such as a biomarker test, can help people better understand their treatment pathways,” explains Dr. Mihaela Druta, a medical oncologist and sarcoma specialist at Moffitt Cancer Centre. “The earlier we can diagnose synovial sarcoma, the better the chance we have of improving treatment outcomes.”
The Importance of Early Diagnosis
Due to its rarity and the subtlety of initial symptoms, synovial sarcoma is often diagnosed at an advanced stage. Dr. Druta underscores the value of early diagnosis and comprehensive disease testing, including biomarker tests, which can:
- Help determine the most appropriate treatment options
- Identify potential eligibility for clinical trials
- Offer clearer insights into how the disease might behave in different areas of the body
As with other soft tissue sarcomas, synovial sarcoma behaves differently depending on its location. This variability means treatment plans must be highly individualised, further emphasising the importance of early and accurate testing.
Spreading Awareness, Saving Lives
Sarcoma Awareness Month is a crucial opportunity to educate the public about the signs and risks associated with synovial sarcoma. As more people become aware of what to look out for—particularly unexplained painful lumps near joints—there is hope that more cases will be caught early, improving patient outcomes and saving lives.
To learn more about biomarker testing and its role in sarcoma treatment, visit:
www.sarcomabiomarkertesting.com